Status:
TERMINATED
Embolectomy in Acute SYlvian Thrombosis in Refractory or Ineligible Patients to ALteplase
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Stroke, Acute
Eligibility:
All Genders
18-82 years
Phase:
NA
Brief Summary
This trial aims at comparing two strategies currently used to address acute ischemic stroke of the middle cerebral artery : medical treatment without endovascular treatment on the one hand, and medica...
Eligibility Criteria
Inclusion
- Radiologically proven acute proximal occlusion of middle cerebral artery
- AND one of the three following :
- tandem internal carotid / middle cerebral artery occlusion
- intravenous thrombolysis contraindicated because of high risk of haemorrhage
- intravenous thrombolysis not possible because of delay \> 4.5 hours
Exclusion
- Impossibility to perform endovascular recanalization within 6h
- Clinically minor stroke (NIHSS score below 5 at baseline)
- Extended cerebral infarction
- Severe comorbidity
- Life expectancy below 3 months before stroke
- Pregnancy or breastfeeding
- modified Rankin Score superior to 2 before stroke
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 24 2017
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT02216565
Start Date
December 1 2014
End Date
August 24 2017
Last Update
December 5 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Henri Mondor
Créteil, France, 94010
2
Fondation Ophtalmologique Adolphe de Rothschild
Paris, France, 75019
3
Hopital Foch
Suresnes, France, 92151